NxStage Stock Receives a Third Buy Rating in a Row
BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.
Read the full article » | Posted 04-12-2017
Related Articles
- ISPD’s Spotlight Webinar Series 2026 Posted 03-12-2026
- Dr. Brigitte Schiller Shares Thoughts on Prescribing Nocturnal Home HD Posted 03-12-2026
- Dr. Chris Chan and Dr. Klement Yeung: Treat Home HD as an Established Modality Posted 03-12-2026
- How to Get Started: Your Path to Home Dialysis – New AKF Webinar Posted 03-12-2026

